In this Viewpoint article, four leading researchers provide their view on the prospect of using tolerogenic cells as an immunotherapy in humans and highlight some of the hurdles that must be addressed for this type of treatment to become a viable therapeutic approach.
机构:
UCL, Med Sch, Dept Metab & Expt Therapeut, Div Med, Gower St, London WC1E 6BT, EnglandUCL, Med Sch, Dept Metab & Expt Therapeut, Div Med, Gower St, London WC1E 6BT, England